Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis

Key Findings

• ●Anakinra effective in TRAPS patients with and without AA amyloidosis
• ●Sustained response over follow-up period
• ●SAA normalisation achieved

Referenced in (1 disease)